首页> 外文会议>2010 5th International Symposium on Health Informatics and Bioinformatics (HIBIT) >Investigation of TEM-1 and SHV-1 beta-lactamase ligand binding
【24h】

Investigation of TEM-1 and SHV-1 beta-lactamase ligand binding

机译:TEM-1和SHV-1β-内酰胺酶配体结合的研究

获取原文
获取原文并翻译 | 示例

摘要

The abuse, overuse and misuse of beta-lactam antibiotics in treating bacterial infections have caused bacteria to develop resistance against them. One common antibiotic resistance mechanism utilized by bacteria is the production of beta-lactamase enzymes that cleave the amide bond in beta-lactam ring rendering the antibiotic ineffective. One way to combat this problem is to use beta-lactamase inhibitors in combination with beta-lactam antibiotics. Beta-lactamase inhibitor protein (BLIP) is an effective inhibitor of class A beta-lactamases such as TEM-1 and SHV-1. In the current research, the binding of BLIP to TEM-1 and to SHV-1 beta lactamase was investigated using molecular dynamics simulations. The binding free energies of BLIP complex with TEM-1 and SHV-1 betalactamases were calculated using Molecular Mechanic Poisson Bolztmann Surface Area (MM-PBSA) methodology. It was found that BLIP has significant differences in binding affinities toward TEM-1 and SHV-1 beta-lactamases.
机译:β-内酰胺抗生素在治疗细菌感染中的滥用,过度使用和滥用已导致细菌对其产生抵抗力。细菌利用的一种常见的抗生素抗药性机制是产生β-内酰胺酶,该酶裂解β-内酰胺环中的酰胺键,使抗生素无效。解决此问题的一种方法是将β-内酰胺酶抑制剂与β-内酰胺类抗生素结合使用。 β-内酰胺酶抑制剂蛋白(BLIP)是A类β-内酰胺酶(如TEM-1和SHV-1)的有效抑制剂。在当前的研究中,使用分子动力学模拟研究了BLIP与TEM-1和SHV-1β内酰胺酶的结合。使用分子力学泊松玻尔兹曼表面积(MM-PBSA)方法计算BLIP复合物与TEM-1和SHV-1β-内酰胺酶的结合自由能。发现BLIP在对TEM-1和SHV-1β-内酰胺酶的结合亲和力上具有显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号